Research Analysts Set Expectations for Allstate Q2 Earnings

The Allstate Co. (NYSE:ALL) – Equities research analysts at Zacks Research cut their Q2 2025 earnings per share estimates for shares of Allstate in a report released on Monday, March 10th. Zacks Research analyst Z. Masood now anticipates that the insurance provider will earn $3.04 per share for the quarter, down from their prior estimate of $3.08. The consensus estimate for Allstate’s current full-year earnings is $18.74 per share. Zacks Research also issued estimates for Allstate’s Q3 2025 earnings at $4.21 EPS, Q4 2025 earnings at $6.40 EPS, FY2025 earnings at $17.65 EPS, Q1 2026 earnings at $5.16 EPS, Q2 2026 earnings at $3.94 EPS, Q4 2026 earnings at $7.28 EPS and FY2026 earnings at $20.98 EPS.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, beating analysts’ consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%.

Several other equities analysts have also weighed in on ALL. Argus raised Allstate from a “hold” rating to a “buy” rating in a report on Monday, March 3rd. Piper Sandler increased their price objective on Allstate from $206.00 to $244.00 and gave the company an “overweight” rating in a report on Tuesday, November 26th. Evercore ISI raised Allstate from an “in-line” rating to an “outperform” rating in a report on Wednesday, January 8th. Barclays reduced their price objective on Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a report on Monday, January 6th. Finally, Wells Fargo & Company raised their price target on Allstate from $186.00 to $187.00 and gave the stock an “equal weight” rating in a report on Tuesday, January 14th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $217.94.

Allstate Stock Performance

Shares of ALL opened at $198.45 on Thursday. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42. The company has a market capitalization of $52.60 billion, a price-to-earnings ratio of 11.68, a PEG ratio of 1.01 and a beta of 0.47. The stock has a 50 day moving average of $191.19 and a 200 day moving average of $192.14. Allstate has a 12 month low of $156.66 and a 12 month high of $209.88.

Institutional Investors Weigh In On Allstate

A number of large investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in shares of Allstate by 1.2% during the fourth quarter. Vanguard Group Inc. now owns 32,635,424 shares of the insurance provider’s stock valued at $6,291,783,000 after buying an additional 389,426 shares during the last quarter. State Street Corp grew its holdings in shares of Allstate by 1.1% during the third quarter. State Street Corp now owns 11,496,306 shares of the insurance provider’s stock valued at $2,190,758,000 after buying an additional 126,922 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Allstate by 2.4% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 9,334,926 shares of the insurance provider’s stock valued at $1,799,681,000 after buying an additional 218,771 shares during the last quarter. Bank of America Corp DE grew its holdings in shares of Allstate by 157.9% during the fourth quarter. Bank of America Corp DE now owns 6,591,138 shares of the insurance provider’s stock valued at $1,270,705,000 after buying an additional 4,035,629 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Allstate by 3.1% during the fourth quarter. Geode Capital Management LLC now owns 6,419,728 shares of the insurance provider’s stock valued at $1,236,060,000 after buying an additional 191,147 shares during the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CFO Jesse E. Merten sold 40,102 shares of the business’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the sale, the chief financial officer now directly owns 18,115 shares of the company’s stock, valued at $3,378,990.95. The trade was a 68.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.80% of the company’s stock.

Allstate Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th will be issued a $1.00 dividend. This is a positive change from Allstate’s previous quarterly dividend of $0.92. This represents a $4.00 annualized dividend and a yield of 2.02%. The ex-dividend date is Monday, March 10th. Allstate’s payout ratio is currently 23.54%.

Allstate declared that its board has initiated a share repurchase plan on Wednesday, February 26th that allows the company to buyback $1.50 billion in shares. This buyback authorization allows the insurance provider to repurchase up to 3% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board of directors believes its stock is undervalued.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.